Diagnostik, Therapie, Verlaufskontrolle und Prävention des diabetischen Fußsyndroms

Inhaltsverzeichnis

 1 Epidemiologie des Diabetischen Fußes
 2 Soziale und ökonomische Faktoren
 3 Pathophysiologie der Fußulzeration
 4 Diabetische Neuropathie
 5 Periphere arterielle Verschlusskrankheit und Diabetes
 6 Biomechanik und Schuhwerk
 7 Behandlungsprinzipien und Ergebnisse beim diabetischen Fußsyndrom
 8 Diabetische Fußinfektionen
 9 Neuro-Osteoarthropathie
10 Amputationen bei Menschen mit Diabetes
11 Prävention
12 Organisation der Fußversorgung
13 Literaturverzeichnis
14 Appendix

Literatur

• 1 Abbott C A, Vileikyte L, Williamson S. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration.  Diabetes Care. 1998;  7 1071-1075
• 2 Abidia A, Laden G, Kuhan G et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial.  Eur J Vasc Endovasc Surg. 2003;  25 513-518
• 3 Adam D J, Beard J D, Cleveland T et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial.  Lancet. 2005;  366 1925-1934
• 4 Afshari M, Larijani B, Fadayee M et al. Efficacy of topical epidermal growth factor in healing diabetic foot ulcers.  Therapy. 2005;  2 759-765
• 5 Ailawadi G, Stanley J C, Williams D M et al. Gadolinium as a nonnephrotoxic contrast agent for catheter-based arteriographic evaluation of renal arteries in patients with azotemia.  J Vasc Surg. 2003;  37 346-352
• 6 Albrektsen S B, Henriksen B M, Holstein P. Minor amputations after revascularization for gangrene.  Acta Orthop Scand. 1997;  68 291-293
• 7 American Diabetes Association. Preventive foot care in diabetes.  Diabetes Care. 2004;  27 Suppl 1 63-64
• 8 American Diabetes Association. Consensus Development Conference on Diabetic Foot Wound Care.  Diabetes Care. 1999;  22 1354-1360
• 9 Andros G, Armstrong D G, Attinger C E et al. Consensus statement on negative pressure wound therapy (V.A.C. Therapy) for the management of diabetic foot wounds.  Ostomy Wound Manage. 2006;  Suppl 1-32
• 10 Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy.  BMJ. 2002;  (324) 71-86
• 11 Apelquvist J. Prognostic value of systolic ankle and toe blood pressure levels.  Diabetes Care. 1989;  12 373-378
• 12 Apelqvist J. Wound healing in diabetes: outcome and costs.  Clin Podiatr Med Surg. 1998;  15 21-40
• 13 Apelqvist J, Agardh C D. The association between clinical factors and outcome of diabetic foot ulcers.  Diabetes Res Clin Pract. 1992;  18 43-53
• 14 Apelqvist J, Armstrong D G, Lavery L A et al. Resource utilization and economic costs of care based on a randomized trial of vacuum-assisted closure therapy in the treatment of diabetic foot wounds.  Am J Surg. 2008;  195(6) 782-788
• 15 Apelqvist J, Larsson J, Agardh C D. The importance of peripheral pulses, peripheral oedema and local pain fort he outcome of diabetic foot ulvers.  Diabet Med. 1990;  7 590-594
• 16 Apelqvist J, Larsson J, Agardh C D. Long-term prognosis for diabetic patients with foot ulcers.  J Int Med. 1993;  233 485-491
• 17 Apelqvist J, Larsson J, Agardh C D. Medical risk factors in diabetic patients with foot ulcers and severe peripheral vascular disease and their influence on outcome.  J Diabetes Compl. 1992;  6 167-174
• 18 Apelqvist J, Castenfors J, Larsson J et al. Wound classification is more important than site of ulceration in the outcome of diabetic foot ulcers.  Diabet Med. 1989;  6 526-530
• 19 Apelqvist J, Castenfors J, Larsson J et al. Ketanserin in the treatment of diabetic foot ulcer with severe peripheral vascular disease.  Int Angiol. 1990;  9 120-124
• 20 Apelqvist J, Larsson J, Agardh C D et al. The influence of external precipitating factors and peripheral neuropathy on the development and outcome of diabetic foot ulcers.  J Diabetes Compl. 1990;  4 21-25
• 21 Apelqvist J, Ragnarson-Tennvall G, Larsson J et al. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting.  Foot Ankle Int. 1995;  16 388-394
• 22 Apelqvist J, Ragnarsson-Tennvall G, Persson U et al. Diabetic foot ulcers in a multidisciplinary setting – an economic analysis of primary healing and healing with amputation.  J Int Med. 1994;  235 463-471
• 23 Arbeitsgemeinschaft Diabetischer Fuß in der Deutschen Diabetesgesellschaft .Empfehlungen zur Amputationsvermeidung beim „Diabetischen Fuß“. 1993; Evidenzklasse IV
• 24 Arkkila P ET, Kantola I M, Viikari J SA. Limited joint mobility in non-insulin dependent diabetic (NIDDM) patients: correlation to control of diabetes, atherosclerotic vascular disease, and other diabetic complications.  J Diabetes Compl. 1997;  11 208-217
• 25 Armstrong D G, Dang C, Nixon B P et al. The hazards of the holiday foot: perons at high risk for diabetic foot ulceration may be more active on holiday.  Diabet Med. 2003;  20 247
• 26 Armstrong D G, Lavery L A, Bushman T R. Peak foot pressures influence the healing time of diabetic foot ulcers treated with total contact casts.  J Rehabil Res Dev. 1998;  35 1-5
• 27 Armstrong D G, Lavery L A, Harkless L B. Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation.  Diabetes Care. 1998;  21 855-859
• 28 Armstrong D G, Lavery L A, Harkless L B. Who is at risk for diabetic foot ulceration?.  Clinics in Podiatric Medicine and Surgery. 1998;  15 11-19
• 29 Armstrong D G, Lavery L A, Holtz-Neiderer K et al. Variability in activity may precede diabetic foot ulceration.  Diabetes Care. 2004;  27 1980-1984
• 30 Armstrong D G, Lavery L A. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial.  Lancet. 2005;  366 1704-1710
• 31 Armstrong D G, Lavery L A, Sariaya M et al. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus.  J Foot Ankle Surg. 1996;  35 280-283
• 32 Armstrong D G, Lavery L A, Stern S et al. Is prophylactic diabetic foot surgery dangerous?.  J Foot Ankle Surg. 1996;  35 585-589
• 33 Armstrong D G, Nguyen H C. Improvement in healing with aggressive edema reduction after debridement of foot infection in persons with diabetes.  Arch Surg. 2000;  135 1405-1409
• 34 Armstrong D G, Nguyen H C, Laverly L A. Off-loading the diabetic foot wound: A randomised clinical trial.  Diabetes Care. 2001;  1 1019-1022
• 35 Armstrong D G, Perales T A, Murff R T et al. Value of white blood cell count with differential in the acute diabetic foot infection.  J Am Podiatr Med Assoc. 1996;  86 224-227
• 36 Armstrong D G, Salas P, Short B et al. Maggot therapy in “lower-extremity hospice” wound care: fewer amputations and more antibiotic-free days.  J Am Podiatr Med Assoc. 2005;  95 254-257
• 37 Armstrong D G, Todd W F, Lavery L A et al. The natural history of acute Charcot’s arthropathy in a diabetic foot speciality clinic.  Diabetic Med. 1997;  14 357-363
• 38 Armstrong D G, Lavery L A, Kimbriel H R et al. Activity pattterns of patients with diabetic foot ulceration.  Diabetes Care. 2003;  26 2595-2597
• 39 Aspelin P, Aubry P, Fransson S G the NEPHRIC study investigators et al. Nephrotoxic effects of high-risk patients undergoing angiography.  N Engl J Med. 2003;  348 491-499
• 40 Attinger C E, Ducic I, Cooper P et al. The role of intrinsic muscle flaps of the foot for bone coverage in foot and ankle defects in diabetic and nondiabetic patients.  Plast Reconstr Surg. 2002;  110 1047-1054
• 41 Avenarius J K, Breek J C, Lampmann L E et al. The additional value of angiography after colour-coded duplex on decision making in patients with critical limb ischaemia. A prospective study.  Eur J Vasc Endovasc Surg. 2002;  23 393-397
• 42 Bamberger D M, Daus G P, Gerding D N. Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy.  Am J Med. 1987;  83 653-660
• 43 Barnes R C. Point: Hyperbaric oxygen is beneficial for diabetic foot wounds.  Clinical Infectious Diseases. 2006;  43 188-192
• 44 Barnett S J, Shield J PH, Potter M J et al. Foot Pathology in Insulin Dependent Diabetes.  Archives of Disease in Childhood. 1995;  73 151-153
• 45 Bartsch T, Brehm M, Falke T et al. Rapid healing of a therapy-refractory diabetic foot after transplantation of autologous bone marrow stem cells.  Medizinische Klinik. 2005;  100 676-680
• 46 Bauer H, Germann G, Gries F A et al. Nationale Versorgungsleitlinie Typ-2-Diabetes-Prävention und Therapie von Fußkomplikationen. Berlin, Düsseldorf: BÄK, AWMF, KBV; 2006
• 47 Baumhauer J F, O’Keefe R J, Schon L C et al. Cytokine-induced osteoclastic bone resorption in charcot arthropathy: an immunohistochemical study.  Foot Ankle Int. 2006;  27 797-800
• 48 Bayram Y, Deveci M, Imirzalioglu N et al. The cell based dressing with living allogenic keratinocytes in the treatment of foot ulcers: a case study.  Br J Plast Surg. 2005;  58 988-996
• 49 Bem R, Jirkovská A, Fejfarová V et al. Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomized controlled trial.  Diabetes Care. 2006;  29 1392-1394
• 50 Berendt A R, Lipsky B. Is this bone infected or not? Differentiating neuro-osteoarthropathy from osteomyelitis in the diabetic foot.  Curr Diab Rep. 2004;  4 424-429
• 51 Berendt A R. Counterpoint: Hyperbaric oxygen for diabetic foot wounds is not effective.  Clinical Infectious Diseases. 2006;  43 193-198
• 52 Bergin S M, Wraight P. Silver based wound dressings and topical agents for treating diabetic foot ulcers. (Review). Cochrane Database of Systematic Reviews 2006, CD005082
• 53 Bettmann M A, Dake M D, Hopkins L N et al. Atherosclerotic Vascular Disease Conference: Writing Group VI: revascularization.  Circulation. 2004;  109 2643-2650
• 54 Bild D E, Selby J V, Sinnock P et al. Lower-extremity amputation in people with diabetes. Epidemiology and prevention.  Diabetes Care. 1989;  12 24-31
• 55 Birck R, Krzossok S, Markowetz F et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis.  Lancet. 2003;  362 598-603
• 56 Birke J A, Rolfsen R J. Evaluation of a Self-Administered Sensory Testing tool to Identify Patients at Risk of Diabetes Related Foot Problems.  Diabetes Care. 1998;  21 23-25
• 57 Birke J A, Pavich M A, Patout Jr C A et al. Comparison of forefoot ulcer healing using alternative off-loading methods in patients with diabetes mellitus.  Adv Skin Wound Care. 2002;  15 210-215
• 58 Blakytny R, Jude E B, Gibson M J et al. Lack of insulin-like growth factor 1 (IGF 1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers.  J Pathol. 2000;  190 589-594
• 59 Bollinger M, Thordarson D B. Partial calcanectomy: an alternative to below knee amputation.  Foot Ankle Int. 2002;  23 927-932
• 60 Borssen B, Bergenheim T, Lithner F. The epidemiology of foot lesions in diabetic patients aged 15–50 years.  Diabet Med. 1990;  7 438-444
• 61 Bouter K P, Storm A J, de Groot R R et al. The diabetic foot in Dutch hospitals: epidemiological features and clinical outcome.  Eur J Med. 1993;  2 215-218
• 62 Boulton A JM. The Pathogenesis of Diabetic Foot Problems: an Overview.  Diabet Med. 1996;  13 12-16
• 63 Boulton A J, Armstrong D G, Albert S F , et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists.  Diabetes Care. 2008;  31 1679-1685
• 64 Boulton A JM, Gries F A, Jervell J A. Guidelines for the Diagnosis and Outpatient Management of Diabetic Peripheral Neuropathy.  Diabet Med. 1998;  15 508-514
• 65 Boulton A JM, Veves A, Young M J. Etiopathogenesis and management of abnormal foot pressures. In: Levin ME, O’Neal LW, Bowker JH, eds. The Diabetic Foot. 5th ed. St. Louis: Mosby Year Book; 1993: 233–246
• 66 Boulton A JM, Vileikyte L, Ragnarson-Tennvall G et al. The global burden of diabetic foot diseases.  Lancet. 2005;  366 1719-1724
• 67 Bowling F L, Salgami E V, Boulton A J. Larval therapy: a novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers.  Diabetes Care. 2007;  30 370-371
• 68 Boyko E J, Ahroni J H, Stensel V. A Prospective Study of Risk Factors for Diabetic Foot Ulcer. The Seattle Diabetic Foot Study.  Diabetes Care. 1999;  22 1036-1042
• 69 Boyko E J, Ahroni J H, Cohen V et al. Prediction of diabetic foot ulcer occurrence using commonly available clinical information. The Seattle Diabetic Foot Study.  Diabetes Care. 2006;  29 1202-1207
• 70 Breuer U. Diabetic patients compliance with bespoke footwear after healing of neuropathic foot ulcers.  Diabete Metabol. 1994;  20 415-419
• 71 Brooks B, Dean R, Patel S et al. TBI or not TBI: that is the question.  Diabet Med. 2001;  18 528-532
• 72 Bus S A, Maas M, Cavanagh P R et al. Plantar fat-pad displacement in neuropathic diabetic patients with toe deformity.  Diabetes Care. 2004;  27 2376-2381
• 73 Bus S A, Maas M, de Lange A et al. Elevated plantar pressures in neuropathic diabetic patients with claw/hammer toe deformity.  Journal of Biomechanics. 2005;  38 1918-1925
• 74 Busch K, Chantelau E. Effectiveness of a new brand of stock ‘diabetic’ shoes to protect against diabetic foot ulcer relapse. A prospective cohort study.  Diabet Med. 2003;  20 665-669
• 75 Calle-Pascual A L, Redondo M J, Ballesteros M. Nontraumatic lower extremity in diabetic and non-diabetic subjects in Madrid, Spain.  Diabet Metab. 1997;  23 519-523
• 76 Calle-Pascual A L, Garcia-Torre N, Moraga I. Epidemiology of nontraumatic lower extremity amputation in Area 7, Madrid, between 1989 and 1999.  Diab Care. 2001;  24 1686-1689
• 77 Caputo C M, Cavanagh P R, Ulbrecht J S et al. Assessment and management of foot disease in patients with diabetes.  New Engl J Med. 1994;  31 854-860
• 78 Caravaggi C, De Giglio R, Pritelli C et al. HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial.  Diabetes Care. 2003;  26 2853-2859
• 79 Chabbert-Buffet N, LeDevehat C, Khodabandhelou T et al. Evidence for Associated Cutaneous Microangiopathy in Diabetic Patients with Neuropathic Foot Ulceration.  Diabetes Care. 2003;  26 960-961
• 80 Carrington A L, Abbott C A, Griffiths J et al. A foot care program for diabetic unilateral lower-limb amputees.  Diabetes Care. 2001;  24 216-221
• 81 Cavanagh P R, Ulbrecht J S, Caputo G M. The Non-Healing Diabetic Foot Wound: Fact or Fiction?.  Ostomy/Wound Management. 1998;  44 Suppl 6-12
• 82 Chantelau E. Hyperbaric oxygen therapy for diabetic foot ulcers.  Diabetes Care. 1997;  20 120
• 83 Chantelau E. The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture.  Diabet Med. 2005;  22 1707-1712
• 84 Chantelau E, Breuer U, Leisch A C. Outpatient treatment of unilateral diabetic foot ulcers with half shoes.  Diabet Med. 1993;  10 267-270
• 85 Chantelau E, Gede A. Foot dimensions of elderly people with and without diabetes mellitus – a data basis for shoe design.  Gerontology. 2002;  48 241-244
• 86 Chantelau E, Haage P. An audit of cushioned diabetic footwear: Relation to patient compliance.  Diabetic Med. 1994;  11 114-116
• 87 Chantelau E, Poll L W. Evaluation of the diabetic charcot foot by MR imaging or plain radiography – an observational study.  Exp Clin Endocrinol Diabetes. 2006;  114 428-431
• 88 Chantelau E, Tanudjaja T, Altenhöfer F et al. Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: a controlled trial.  Diabet Med. 1996;  13 156-159
• 89 Claus D, Carvalho V P, Neundorfer B et al. Perception of Vibration. Normal Findings and Methologic Aspects.  Nervenarzt. 1988;  59 138-142
• 90 Collins T C, Suarez-Almazor M, Petersen N. An absent pulse is not sensitive for the early detection of peripheral arterial disease.  Fam Med. 2006;  38 38-42
• 91 Connelly J, Airey M, Chell S. 2001. Variation in clinical decision making is a partial explanation for geographical variation in lower extremity amputation rates.  Br J Surg. 2001;  88 529-535
• 92 Conrad B, Ceballos O. Bewegungsstörungen in der Neurologie. In: Baumann, Hrsg. Georg Thieme, Stuttgart: 1996: 287 ff
• 93 Cunha B A. Antibiotic selection for diabetic foot infections: a review.  J Foot Ankle Surg. 2000;  39 253-257
• 94 D’Ambrogi E, Giacomozzi C, Macellari V et al. Abnormal foot function in diabetic patients: the altered onset of Windlass mechanism.  Diabetic Medicine. 2005;  22 1713-1719
• 95 Dangas G, Iakovou I, Nikolsky E et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic ­kidney disease and hemodynamic variables.  Am J Cardiol. 2005;  95 13-19
• 96 Dargis V, Pantelejeva O, Jonushaite A. Benefits of a Multidisciplinary Approach in the Management of Recurrent Diabetic Foot Ulceration in Lithuania. A prospective study.  Diabetes Care. 1999;  22 1428-1431
• 97 Day J. Diabetic Patient Education: Determinants of Success.  Diabetes Metabolism Research and Reviews. 2000;  16 (Suppl 1) 70-74
• 98 De Sonnaville J JJ, Colly L P, Wijkel D et al. The prevalence and determinants of foot ulceration in type 2 diabetic patients in a primary health care setting.  Diabetes Research and Clin Pract. 1997;  35 149-156
• 99 Deutsche Diabetesgesellschaft .Evidenzbasierte Diabetes-Leitlinien DDG. Diagnostik, Therapie und Verlaufskontrolle der sensomotorischen diabetischen Neuropathien. 2000
• 100 Deutsche Gesellschaft für Gefäßchirurgie .Leitlinie zur amputationsbedrohten Extremität. Köln: Deutscher Ärzteverlag; 1998
• 101 Dormandy J A, Rutherford R B. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).  J Vasc Surg. 2000;  31 1-296
• 102 Dorros G, Jaff M R, Dorros A M et al. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with crit­ical limb ischemia: five-year follow-up.  Circulation. 2001;  104 2057-2062
• 103 Ebskov L B. Epidemiology of lower limb amputation in diabetics in Denmark.  Int Orthop. 1991;  115 285-288
• 104 Ebskov B, Josephsen P. Incidence of reamputation and death for gangrene of the lower extremity.  Prosthet Orthot Int. 1980;  4 77-80
• 105 Edelson G W, Armstrong D G, Lavery L A et al. The acutely infected diabetic foot is not adequately evaluated in an inpatient setting.  Arch Intern Med. 1996;  156 2373-2378
• 106 Edmonds M E, Blundell M P, Morris M E et al. Improved survival of the diabetic foot: the role of a specialised foot clinic.  QJ Med New Series. 1986;  60 763-771
• 107 Edmonds M E, Petrova N L, Edmonds A et al. A new staging system for Charcot osteoarthropathy incorporating MRI abnormalities. 5th International Symposium on the Diabetic Foot. 2007: 132
• 108 El-Shazly M, Abdel-Fattah M, Scorpiglione N. Risk factors for lower limb complications in diabetic patients.  Diabetes Compl. 1998;  12 10-17
• 109 Emanuele M A, Buchanan B J, Abraira C. Elevated leg systolic pressures and arterial calcification in diabetic occlusive vascular disease.  Diabetes Care. 1981;  4 289-292
• 110 Embil J M, Papp K, Sibbald G et al. Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy.  Wound Repair Regen. 2000;  8 162-168
• 111 Embil J M, Rose G, Trepmann E et al. Oral antimicrobial therapy for diabetic foot osteomyelitis.  Foot Ankle Int. 2006;  27 771-779
• 112 Eneroth M, Apelqvist J, Stenstrom A. Clinical characteristics and outcome in 223 diabetic patients with deep foot infections.  Foot Ankle Int. 1997;  18 716-722
• 113 Eneroth M, Larsson J, Oscarsson C et al. Related Articles, Links, Nutritional supplementation for diabetic foot ulcers: the first RCT.  J Wound Care. 2004;  13 230-234
• 114 Engelhardt M, Bruijnen H, Schaal J et al. Risk factors for survival in patients with end-stage renal disease undergoing infrainguinal bypass surgery.  Vasa. 2005;  34 250-254
• 115 Ergun I, Keven K, Uruc I et al. The safety of gadolinium in patients with stage 3 and 4 renal failure.  Nephrol Dial Transplant. 2006;  21 697-700
• 116 Ertugrul M B, Baktiroglu S, Salman S et al. The diagnosis of osteomyelitis of the foot in diabetes: Microbiological examination vs. magnetic resonance imaging and labelled leucocyte scanning.  Diabetic Medicine. 2006;  23 649-653
• 117 Fabrin J, Larsen K, Holstein P E. Long-term Follow-Up in Diabetic Charcot Feet with Spontaneous Onset.  Diabetes Care. 2000;  23 796
• 118 Faglia E, Favales F, Aldeghi A et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study.  Diabetes Care. 1996;  19 1338-1343
• 119 Faglia E, Favales F, Quarantiello A. Angiographic evaluation of peripheral arterial occlusive disease and its role as a prognostic determinant for major amputation in diabetic subjects with foot ulcer.  Diabetes Care. 1998;  4 625-630
• 120 Faglia E, Favales F, Morabito A. New ulceration, new major amputation, and survival rates in diabetic subjects hospitalized for foot ulceration from 1990 to 1993: a 6.5-year follow-up.  Diabetes Care. 2001;  24 78-83
• 121 Faglia E, Mantero M, Caminiti M et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects.  J Intern Med. 2002;  252 225-232
• 122 Falanga V. Wound healing and its impairment in the diabetic foot.  Lancet. 2005;  366 1736-1743
• 123 Falkenberg M. Metabolic control and amputations among diabetics in primary health care – a population-based intensified program governed by patient education.  Scand J Prim Health Care. 1990;  8 25-29
• 124 Flack S, Apelqvist J, Keith M et al. An economic evaluation of VAC therapy compared with wound dressings in the treatment of diabetic foot ulcers.  J Wound Care. 2008;  17 71-78
• 125 FDA, public health advisory update on magnetic resonance imaging (MRI). Contrast agents containing gadolinium and nephrogenic fibrosing dermatopathy. 2006; http://www.fda.gov/cder/drug/davisory/gadolinium_agents_20061222
• 126 Frykberg R G. Charcot Foot. An Update on Pathogenesis and Management. In: Boulton AJM, The Foot in Diabetes 3rd ed. Hrsg. John Wiley & Sons Ltd., Chichester; 2000: 235–260
• 127 Frykberg R G, Mendeszoon E. Management of the Diaebetic Charcot Foot.  Diabetes Metabolism Research and Reviews. 2000;  16 (Suppl 1) 59-65
• 128 Game F L, Jeffcoate W J. Primarily non-surgical management of osteomyelitis of the foot in diabetes.  Diabetologia. 2008;  51 962-967
• 129 Garg P K, Tian L, Criqui M H et al. Physical Activity During Daily Life and Mortality in Patients With Peripheral Arterial Disease.  Circulation. 2006;  114 242-248
• 130 Garrow A P, van Schie C H, Boulton A J. Efficacy of multilayered hosiery in reducing in-shoe plantar foot pressure in high-risk patients with diabetes.  Diabetes Care. 2005;  28 2001-2006
• 131 Gentzkow G D, Iwasaki S D, Hershon K S et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers.  Diabetes Care. 1996;  19 350-354
• 132 Gordois A, Scuffham P, Shearer A. The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S.  Diabetes Care. 2003;  26 1790-1795
• 133 Goodridge D, Trepman E, Sloan J et al. Quality of life of adults with unhealed and healed diabetic foot ulcers.  Foot & Ankle International. 2006;  27 274-280
• 134 Grayson M L, Gibbons G W, Habershaw G M. Use of ampicillin / sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients.  Clin Infect Dis. 1994;  18 683-693
• 135 Grayson M L, Gibbons G W, Balogh K. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients.  JAMA. 1995;  273 721-723
• 136 Greenman R L, Panasyuk S, Wang X et al. Early changes in the skin microcirculation and muscle metabolism of the diabetic foot.  Lancet. 2005;  366 1711-1717
• 137 Griffiths G D, Wieman T J. Metatarsal head resection for diabetic foot ulcers.  Arch Surg. 1990;  125 832-835
• 138 Group T G. Epidemiology of lower extremity amputation in centres in Europe, North America and East Asia. The global lower extremity amputation study group.  Br J Surg. 2000;  87 328-337
• 139 Grundy S M, Garber A, Goldberg R et al. Prevention Conference VI: Diabetes and Cardiovascular Disease. Writing Group IV: Lifestyle and Medical Management of Risk Factors.  Circulation. 2002;  105 e153-e158
• 140 Hagberg E, Berlin O K, Renstrom P. Function after through-knee compared with below-knee and above-knee amputation.  Prosthet Orthot Int. 1992;  16 168-173
• 141 Haider S N, Kavanagh E G, Forlee M et al. Two-year outcome with preferential use of infrainguinal angioplasty for critical ischemia.  J Vasc Surg. 2006;  43 504-512
• 142 Hailey D, Jacobs P, Perry D C et al. Overview of Adjunctive Hyperbaric Oxygen Therapy for Diabetic Foot Ulcer. (Technology overview no 25). Ottawa: Canadian Ageny for Drugs and Technologies in Health; 2007
• 143 Hampson J P, Roberts R I, Morgan D A. Shared care: a review of the literature.  Family Practice. 1996;  13 264-279
• 144 Hanft J R, Goggin J P. The Role of Combined Magnetic Field Bone Growth Stimulation as an Adjunct in the Treatment of Neuroarthropathy / Charcot Joint: An Expanded Pilot Study.  Journal of Foot and Ankle Surgery. 1998;  37 510-515
• 145 Harding K G, Jones V P, Price P. Topical treatment: which dressing to choose.  Diabet Metab Res Rev. 2000;  16 (Suppl. 11) 547-550
• 146 Hartemann-Heurtier A, Robert J, Jaqueminet S et al. Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact.  Diabetic Medicine. 2004;  21 710-715
• 147 Hartnell G. MRAngiography Compared With Digital Subtraction Angiography.  AJR. 2000;  175 1188-1189
• 148 Harrison S J, Cochrane L, Abboud R J et al. Do patients with diabetes wear shoes of the correct size?.  Int J Clin Pract. 2007;  61 1900-1904
• 149 Ha Van G, Siney H, Danan J P et al. Treatment of osteomyelitis in the diabetic foot. Contribution of conservative surgery.  Diabetes Care. 1996;  19 1257-1260
• 150 Ha Van G, Siney H, Hartmann-Heurtier A et al. Nonremovable, windowed, fiberglass cast boot in the treatment of diabetic plantar ulcers.  Diabetes Care. 2003;  26 2848-2852
• 151 Hayes T M, Harries J M. Randomised controlled trial of routine hospital clinic care versus routine general practice care for Type II diabetics.  British Medical Journal. 1984;  289 728-730
• 152 Hehenberger K, Kratz G, Hansson A et al. Fibroblasts derived from human chronic diabetic wounds have a decreased proliferation rate, which is recovered by the addition of heparin.  J Dermatol Sci. 1998;  16 144-151
• 153 Heller G, Günster C, Schellschmidt H. Wie häufig sind Diabetes-bedingte Amputationen unterer Extremitäten in Deutschland? Eine Analyse auf Basis von Routinedaten.  Dtsch Med Wochenschr. 2004;  129 429-433
• 154 Heller G, Gunster C, Swart E. The frequency of lower limb amputations in Germany.  Dtsch Med Wochenschr. 2005;  130 1689-1690
• 155 Hickman M, Drummond N, Grimshaw J. A taxonomy of shared care for chronic disease.  Journal of Public Health Medicine. 1994;  16 447-454
• 156 Hilz M J, Axelrod F B. Normative Values of Vibratory Perception in 530 Children, Juveniles and Adults Aged 3–79 Years.  Journal of Neurological Science. 1998;  159 219-225
• 157 Hinman C D, Maibach H I. Effect of air exposure and occlusion on experimental human skin wounds.  Nature. 1963;  200 377-378
• 158 Hirschl M, Hirschl A M. Bacterial flora in mal perforant and antimicrobial treatment with ceftriaxone.  Chemotherapy. 1992;  38 275-280
• 159 Hissink R J, Manning H A, van Baal J G. The MABAL shoe, an alternative method in contact casting for the treatment of neuropathic diabetic foot ulcers.  Foot Ankle Int. 2000;  21 320-323
• 160 Holstein P. The distal blood pressure predicts healing of amputations on the feet.  Acta Orthop Scand. 1984;  55 227-233
• 161 Huang P, Li S, Han M et al. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes.  Diabetes Care. 2005;  28 2155-2160
• 162 Hoffmann U, Fischereder H, Reil A et al. Renal effects of gadopentate dimeglumine in patients with normal and impaired renal function.  Eur J Med Res. 2005;  20 149-154
• 163 Holstein P, Ellitsgaard N, Olsen B B et al. Decreasing incidence of major amputations in people with diabetes.  Diabetologia. 2000;  43 844-847
• 164 Hoskins P L, Fowler P M, Constantino M et al. Sharing the care of diabetic patients between hospital and general practitioners: does it work?.  Diabet Med. 1993;  10 81-86
• 165 Humphreys W. The painful red foot-inflammation or ischemia?.  BMJ. 1999;  318 925-926
• 166 Hutchinson A, McIntosh A, Feder G et al. Clinical Guidelines and Evidence Review for Type 2 Diabetes: Prevention and Management of Foot Problems. London: Royal College of General Practitioners; 2000
• 167 Ince P, Kendrick D, Game F et al. The association between baseline characteristics and the outcome of foot lesions in a UK population with diabetes.  Diabet Med. 2007;  24 977-981
• 168 International Consensus Working Group .International consensus on diagnosing and treating the infected diabetic foot. 2003
• 169 International Consensus Working Group .Progress report: Wound Healing and Treatment of people with Diabetic Foot Ulcers. 2003
• 170 Internationale Arbeitsgruppe über den Diabetischen Fuß .Internationaler Consensus über den Diabetischen Fuß 1999. Mainz: Kirchheim Verlag; 1999
• 171 International Working Group on the Diabetic Foot .International Consensus on the Diabetic Foot. 2007
• 172 International Diabetes Federation (IDF) . Global Guideline for Type 2 Diabetes.  Foot Care. 2005;  15 58-62
• 173 Ismail K, Winkley K, Stahl D et al. A cohort study of people with diabetes and their first foot ulcer: the role of depression on mortality.  Diabetes Care. 2007;  30 1473-1479
• 174 Izumi Y, Satterfield K, Lee S et al. Risk of reamputation in diabetic patients stratified by limb and level of amputation: A 10-year observation.  Diabetes Care. 2006;  29 566-570
• 175 Jeandrot A, Richard J L, Combescure C et al. Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study.  Diabetologia. 2008;  51 347-352
• 176 Jeffcoate W J, Game F, Cavanagh P R. The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes.  Lancet. 2005;  10 2058-2061
• 177 Jeffcoate W J, Chipchase S Y, Ince P et al. Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures.  Diabetes Care. 2006;  29 1784-1787
• 178 Jeffcoate W J, van Houtum W H. Amputation as a marker of the quality of foot care in diabetes.  Diabetologia. 2004;  47 2051-2058
• 179 Johansson K EA, Marklund B RG, Fowelin J HR. Evaluation of a new screening method for detecting peripheral arterial disease in a primary health care population of patients with diabetes mellitus.  Diabet Med. 2002;  19 307-310
• 180 Jörneskog G, Brismar K, Fagrell B. Skin Capillary Circulation is More Impaired in the Toes of Diabetic than Non-Diabetic Patients with Vascular Disease.  Diabetic Medicine. 1995;  12 36-41
• 181 Jo S H, Youn T J, Koo B K et al. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.  J Am Coll Cardiol. 2006;  48 924-930
• 182 Johnson M, Newton P, Goyder E. Patient and professional perspectives on prescribed therapeutic footwear for people with diabetes: A vignette study.  Patient Education & Counselling. 2006;  64 167-172
• 183 Jude E B, Blakytny R, Bulmer J et al. Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers.  Diabet Med. 2002;  19 440-447
• 184 Jude E B, Samson O, Oyibo S O et al. Peripheral Arterial Disease in Diabetic and nondiabetic Patients. A comparison of severity and outcome.  Diabetes Care. 2001;  24 1433-1437
• 185 Jude E B, Selby P L, Burgess J et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.  Diabetologia. 2001;  44 2032-2037
• 186 Jude E B, Apelqvist J, Spraul M et al. Prospective randomized controlled study of Hydrofiber dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers.  Diabetic Medicine. 2007;  24 280-288
• 187 Kästenbauer T, Sauseng S, Brath H et al. The value of the Rydel-Seiffer tuning fork as a predictor of diabetic polyneuropathy compared with a neurothesiometer.  Diabetic Medicine. 2004;  21 563-567
• 188 Kästenbauer T, Sokol G, Auinger M et al. Running shoes for relief of plantar pressure in diabetic patients.  Diabet Med. 1998;  15 518-522
• 189 Kalani M, Apelqvist J, Blomb M et al. Effect of Dalteparin on Healing of Chronic Foot Ulcers in Diabetic Patients With Peripheral Arterial Occlusive Disease.  Diabetes Care. 2003;  26 2575-2580
• 190 Kallio M, Forsblom C, Groop P H et al. Development of new peripheral arterial occlusive disease in patients with type 2 diabetes during a mean follow-up of 11 years.  Diab Care. 2003;  26 1241-1245
• 191 Karp N S, Kasabian A K, Siebert J W et al. Microvascular free-flap salvage of the diabetic foot: a 5-year experience.  Plast Reconstr Surg. 1994;  94 834-840
• 192 Katz I A, Harlan A, Miranda-Palma B et al. A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers.  Diabetes Care. 2005;  28 555-559
• 193 Kessler L, Piemont Y, Ortega F et al. Comparison of microbiological results of needle puncture vs. superficial swap in infected diabetic foot ulcer with osteomyelitis.  Diabetic Medicine. 2006;  23 99-102
• 194 Klenerman L, McCabe C, Cogley D. Screening for patients at risk of diabetic foot ulceration in a general diabetic outpatient clinic.  Diabet Med. 1996;  13 561-563
• 195 Koelemay M J, den Hartog D, Prins M H et al. Diagnosis of arterial disease of the lower extremities with duplex ultrasound.  Br J Surg. 1996;  83 404-409
• 196 Kranke P, Bennett M, Roeckl-Wiedmann I et al. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2004; (2):CD004123
• 197 Kreitner K F, Kalden P, Neufang A et al. Diabetes and Peripheral Arterial Occlusive Disease: Prospective Comparison of Contrast-Enhanced Three-Dimensional MR Angiography with Conventional Digital Subtraction Angiography.  AJR. 2000;  174 171-179
• 198 Kumar S, Ashe H A, Parnell L N. The prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population based study.  Diabet Med. 1994;  11 480-484
• 199 Kumar S, Fernando D JS, Veves A. Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration.  Diabetes Res Clin Pract. 1991;  13 63-68
• 200 Larsen K, Holstein P E. Stress Fractures as the Cause of Charcot Feet. In: Bakker K, ed. Proceedings of the First International Symposium on the Diabetic Foot. Amsterdam: Excerpta Medica; 1991: 108–116
• 201 Larsson J, Apelqvist J, Agardh C D et al. Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach?.  Diabet Med. 1995;  12 770-776
• 202 Larsson J, Apelqvist J, Castenfors J et al. Distal blood pressure as a predictor for the level of amputation in diabetic patients with foot ulcer.  Foot and Ankle. 1993;  14 247-253
• 203 Larsson J, Agardh C D, Apelqvist J et al. Long-term prognosis after healed amputation in patients with diabetes.  Clin Orthop. 1998;  350 149-158
• 204 Lavery L A, Armstrong D G, Vela S A et al. Practical criteria for screening patients at high risk for diabetic foot ulceration.  Arch Intern Med. 1998;  15 157-162
• 205 Lavery L A, Armstrong D G, Vela S A et al. Practical criteria for screening patients at high risk for diabetic foot ulceration.  Arch Intern Med. 1998;  15 157-162
• 206 Lavery L A, Armstrong D G, Wunderlich R P et al. Predictive value of foot pressure assessment as part of a population-based diabetes disease management program.  Diabetes Care. 2003;  26 1069-1073
• 207 Lavery L A, Armstrong D G, Wunderlich R P et al. Risk factors for foot infections in individuals with diabetes.  Diabetes Care. 2006;  29 1288-1293
• 208 Lavery L A, Armstrong D G, Peters E J et al. Probe-to-bone test for diagnosing diabetic foot osteomyelitis: reliable or relic?.  Diabetes Care. 2007;  30 270-274
• 209 Lavery L A, Barnes S A, Keith M S et al. Prediction of healing for postoperative diabetic foot wounds based on early wound area progression.  Diabetes Care. 2008;  31 26-29
• 210 Lavery L A, Higgins K R, Lanctot D R et al. Preventing diabetic foot ulcer recurrence in high-risk patients: use of temperature monitoring as a self-assessment tool.  Diabetes Care. 2007;  30 14-20
• 211 Lavery L A, Peters E J, Williams J R et al. Foot. Reevaluating the way we classify the diabetic foot: restructuring the diabetic foot risk classification system of the International Working Group on the Diabetic Foot.  Diabetes Care. 2008;  31 154-156
• 212 Lavery L A, Van Houtum W H, Armstrong D G. Institutionalization following diabetes-related lower extremity amputation.  Am J Med. 1997;  103 383-388
• 213 Lavery L A., Van Houtum W H, Harkless L B. In-hospital mortality and disposition of diabetic amputees in The Netherlands.  Diabet Med. 1996;  13 192-197
• 214 Levin M E. Preventing Amputation in the Patient with Diabetes.  Diabetes Care. 1995;  18 1383-1394
• 215 Lee J S, Lu M, Lee V S et al. Lower-extremity amputation. Incidence, risk factors, and mortality in the Oklahoma Indian Diabetes Study.  Diabetes. 1993;  42 876-882
• 216 Leese G P, Reid F, Green V et al. Stratification of foot ulcer risk in patients with diabetes: A population-based study.  International Journal of Clinical Practice. 2006;  60 541-545
• 217 Legat F J, Krause R, Zenahlik P et al. Penetration of piperacillin and tazobactam into inflamed soft tissue of patients with diabetic foot infection.  Antimicrob Agents Chemother. 2005;  49 4368-4371
• 218 Lefrandt J D, Bosma E, Oomen P HN et al. Sympathetic mediated vasomotion and skin capillary permeability in diabetic patients with peripheral neuropathy.  Diabetologia. 2003;  46 40-47
• 219 Lepore G, Maglio M L, Cuni C et al. Poor glucose control in the year before admission as a powerful predictor of amputation in hospitalized patients with diabetic foot ulceration.  Diabetes Care. 2006;  29 1985
• 220 Leslie C A, Sapico F L, Ginunas V J et al. Randomized controlled trial of topical hyperbaric oxygen for treatment of diabetic foot ulcers.  Diabetes Care. 1988;  11 111-115
• 221 Lipsky B A. Osteomyelitis of the foot in diabetic patients.  Clin Infect Dis. 1997;  25 1318-1326
• 222 Lipsky B A, Baker P D, Landon G C et al. Antibiotic therapy for diabetic foot infections: comparison of two parental-to-oral regimens.  Clin Infect Dis. 1997;  24 643-648
• 223 Lipsky B A, Armstrong D G, Citron D M et al. Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial.  Lancet. 2005;  12 1695-1703
• 224 Lipsky B A, Berendt A R, Deery H G et al. Infectious Diseases Society of America. Diagnosis and treatment of diabetic foot infections.  Clin Infect Dis. 2004;  39 885-910
• 225 Lipsky B A, Pecoraro R E, Larson S A et al. Outpatient management of uncomplicated lower-extremity infections in diabetic patients.  Arch Intern Med. 1990;  150 790-797
• 226 Lipsky B A, Stoutenburgh U. Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections.  J Antimicrob Chemother. 2005;  55 240-245
• 227 Litzelman D K, Marriot D JM, Vinicor F. Independent physiological predictors of foot lesions in patients with NIDDM.  Diabetes Care. 1997;  20 1273-1278
• 228 Litzelman D K, Marriot D JM, Vinicor F. The role of footwear in the prevention of foot lesions in patients with NIDDM.  Diabetes Care. 1997;  20 156-162
• 229 Litzelman D, Slemenda W, Langefeld C et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. A randomized, controlled trial.  Ann of Intern Med. 1993;  119 36-41
• 230 Lobmann R, Ambrosch A, Schultz G et al. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients.  Diabetologia. 2002;  45 1011-1016
• 231 Lobmann R, Müller E, Kersken J et al. The diabetic Foot in Germany: analysis of quality in specialised diabetic foot care centres.  The Diabetic Foot Journal. 2007;  10 68-72
• 232 Lobmann R, Pittasch D, Muhlen I et al. Autologous human keratinocytes cultured on membranes composed of benzyl ester of hyaluronic acid for grafting in nonhealing diabetic foot lesions: a pilot study.  J Diabetes Complications. 2003;  17 199-204
• 233 Lobmann R, Schultz G, Lehnert H. Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications.  Diabetes Care. 2005;  28 461-471
• 234 LoGerfo F W, Coffman J D. Vascular and microvascular disease of the foot in diabetes. Implications for foot care.  New Engl J Med. 1984;  311 1615-1619
• 235 Loo V G, Poirier L, Miller M A et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile – associated diarrhea with high morbidity and mortality.  N Engl J Med. 2005;  353 2442-2449
• 236 Lundin M, Wiksten J P, Peräkylä T et al. Distal pulse palpation; is it reliable?.  World J Surg. 1999;  23 252-255
• 237 Macfarlane R M, Jeffcoate W J. Factors contributing to the presentation of diabetic foot ulcers.  Diabetic Med. 1997;  14 867-870
• 238 Madani S F, Stammler C, Muller U A. The frequency of lower-limb amputations in people with diabetes in the German state of Thuringia.  Diabetes und Stoffwechsel. 1999;  8 201-206
• 239 Maciejewski M L, Reiber G E, Smith D G et al. Effectiveness of diabetic therapeutic footwear in preventing reulceration.  Diabetes Care. 2004;  27 1774-1782
• 240 Malone J M, Snyder M, Anderson G et al. Prevention of amputation by diabetic education.  Am J Surg. 1989;  158 520-524
• 241 Mantey I, Foster A V, Spencer S et al. Why do foot ulcers recur in diabetic patients?.  Diabet Med. 1999;  16 245-249
• 242 Marciniak M. Qualifizierte Fußpflege/Behandlung zur Rehabilitation von Patienten mit diabetischem Fuß-Syndrom. Eine Kohortenstudie.  Diabetes und Stoffwechsel. 1998;  7 81-85
• 243 Marston W A, Hanft J, Norwood P et al. Dermagraft Diabetic Foot Ulcer Study Group. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial.  Diabetes Care. 2003;  26 1701-1705
• 244 Martinez-de Jesus F R, Morales-Guzman M, Castaneda M et al. Randomized single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers.  Arch Med Res. 1997;  28 95-99
• 245 Mason J, O’Keeffe C, Hutchinson A et al. A systematic review of foot ulcer in patients with Type 2 diabetes mellitus. II: treatment.  Diabet Med. 1999;  16 889-909
• 246 Margolis D J, Allen-Taylor L, Hoffstad O et al. Diabetic neuropathic foot ulcers: predicting which ones will not heal.  Am J Med. 2003;  115 627-631
• 247 Margolis D J, Hofstad O, Feldman H I. The association between renal failure and foot ulcer or lower extremity amputation in those patients with diabetes.  Diabetes Care. 2008;  ,  Epub ahead of print
• 248 Marston W A, Hanft J, Norwood P et al. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial.  Diabetes Care. 2003;  26 1701-1705
• 249 McCabe C J, Stevenson R C, Dolan A M. Evaluation of a diabetic foot screening and protection program.  Diabetic Med. 1998;  15 80-84
• 250 McCullough P A, Bertrand M E, Brinker J A et al. A meta-analysis of the renal safety of isoosmolar iodixanol compared with low-osmolar contrast media.  J Am Coll Cardiol. 2006;  48 692-699
• 251 McDonald L C, Killgore G E, Thompson A et al. An epidemic toxic gene-variant strain of Clostridium difficile.  N Engl J Med. 2005;  353 2433-2441
• 252 McGrath N M, Curran B A. Recent commencement of dialysis is a risk factor for lower-extremity amputation in a high-risk diabetic population.  Diabetes Care. 2000;  23 432-433
• 253 McNeely M J, Boyko E J, Ahroni J H. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration.  Diabetes Care. 1995;  18 216-219
• 254 Meijer J -WG, Smit A J, van der Hoeven J H et al. Back to the basics in diagnosing diabetic polyneruopathy with the tuning fork!.  Diabetes Care. 2005;  28 2201-2205
• 255 Merten G J, Burgess W P, Gray L V et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial.  JAMA. 2004;  291 2328-2334
• 256 Miranda-Palma B, Sosenko J M, Bowker J H et al. A comparison of the monofilament with other testing modalities for foot ulcer susceptibility.  Diabetes Research & Clinical Practice. 2005;  70 8-12
• 257 Misuri A, Lucertini G, Nanni A et al. Predictive value of transcutaneous oximetry for selection of the amputation level.  J Cardiovasc Surg. 2000;  41 83-87
• 258 Moore T J, Barron J, Hutchinson 3rd  F et al. Prosthetic usage following major lower extremity amputation.  Clin Orthop. 1989;  238 219-224
• 259 Morbach S, Mollenberg J, Quante C et al. Diabetic holiday foot syndrome – the dimension of the problem and patients’ characteristics.  Pract Diabetes Int. 2001;  18 48-50
• 260 Morgan C L, McEwan P, Morrissey M et al. Characterization and comparison of health-related utility in people with diabetes with various single and multiple vascular complications.  Diabetic Medicine. 2006;  23 1100-1105
• 261 Morris A D, McAlpine R, Steinke D. Diabetes and lower limb amputations in the community. A retrospective cohort study.  Diabetes Care. 1998;  5 738-743
• 262 Mueller M J, Diamond J E, Sinacore D R. Total contact casting in treatment of diabetic plantar ulcers. Controlled clinical trial.  Diabetes Care. 1989;  12 384-388
• 263 Müller E. Pathophysiologie und Pathogenese des diabetischen Fußsyndroms.  Der Diabetologe. 2006;  2 9-17
• 264 Muntner P, Wildman R P, Reynolds K et al. Relationship between HbA1c level and peripheral arterial disease.  Diabetes Care. 2005;  28 1981-1987
• 265 Muller M, Trocme C, Lardy B et al. Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing.  Diabet Med. 2008;  25 419-426
• 266 Murray H J, Young M J, Hollis S et al. The Association Between Callus Formation, High Pressure and Neuropathy in Diabetic Foot Ulceration.  Diabet Med. 1996;  13 979-982
• 267 Myerson M, Papa J, Eaton K. The total contact cast for management of neuropathic plantar ulceration of the foot.  J Bone Joint Surg [Am]. 1992;  74 261-269
• 268 Nabuurs-Franssen M H, Sleegers R, Huijberts M SP et al. Total contact casting of the diabetic foot in daily practice: a prospective follow-up study.  Diabetes Care. 2005;  28 243-247
• 269 Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency.  Am J Kidney Dis. 2002;  39 930-936
• 270 Nelson E A, O’Meara S, Golder S et al. DASIDU Steering Group Systematic review of antimicrobial treatments for diabetic foot ulcers.  Diabet Med. 2006;  23 348-355
• 271 Niezgoda J A, Van Gils C C, Frykberg R G et al. Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic ulcers.  Adv Skin Wound Care. 2005;  18 258-266
• 272 Nixon B P, Armstrong D G, Wendell C et al. Do US veterans wear appropriately sized shoes?: the Veterans Affairs shoe size selection study.  J Am Podiatr Med Assoc. 2006;  96 290-292
• 273 Norman P E, Davis W A, Bruce D G et al. Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study.  Diabetes Care. 2006;  29 575-580
• 274 Norgren L, Hiatt W R. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).  Eur J Vasc Surg. 2007;  33 (Suppl. 1) 1-75
• 275 O’Meara S M, Cullum N A, Majid M et al. Systematic review of antimicrobial agents used for chronic wounds.  Br J Surg. 2001;  88 4-21
• 276 O’Meara S, Cullum N, Majid M et al. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds, (4) diabetic foot ulceration.  Health Technol Assess. 2000;  4 1-237
• 277 O’Meara S, Nelson E A, Golder S and DASIDU Steering Group et al. Systematic review of methods to diagnose infection in foot ulcers in diabetes.  Diabet Med. 2006;  23 341-347
• 278 Oyibo S O, Jude E B, Tarawneh I et al. The effects of ulcer size and site, patient’s age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers.  Diabet Med. 2001;  18 133-138
• 279 Oyibo S O, Jude E B, Tarawneh I et al. A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems.  Diabetes Care. 2001;  24 84-88
• 280 Padberg F T, Back T L, Thompson P N et al. Transcutaneous oxygen (TcPO₂) estimates probability of healing in the ischemic extremity.  J Surg Res. 1996;  60 365-369
• 281 Panayiotopoulos Y P, Tyrrell M R, Arnold F J et al. Results and cost analy­sis of distal [crural / pedal] arterial revascularisation for limb salvage in diabetic and non-diabetic patients.  Diabet Med. 1997;  14 214-220
• 282 Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrast-induced nephropathy.  JAMA. 2006;  295 2765-2779
• 283 Pecoraro R E, Reiber G E, Burgess E M. Pathways to diabetic limb amputation: basis for prevention.  Diabetes Care. 1990;  113 516-521
• 284 Pellizzer G, Strazzabosco M, Presi S. Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection.  Diabet Med. 2001;  18 822-827
• 285 Perkins B A, Zinman B, Olaleye D et al. Simple screening tests for peripheral neuropathy in the diabetes clinic.  Diabetes Care. 2001;  24 250-256
• 286 Peters E J, Lavery L A, Armstrong D G et al. Electric stimulation as an adjunct to heal diabetic foot ulcers: a randomized clinical trial.  Arch Phys Med Rehabil. 2001;  82 721-725
• 287 Petre M, Tokar P, Kostar D et al. Revisiting the total contact cast.  Diabetes Care. 2005;  28 929-930
• 288 Pham H, Harkless L B, Armstrong D G. Screening Techniques to Iden­tify People at High Risk for Diabetic Foot Ulceration.  Diabetes Care. 2000;  23 606-611
• 288a Piaggesi A, Macchiarini S, Rizzo L et al. An off-the-shelf instant contact casting device for the management of diabetic foot ulcers: a randomized prospective trial versus traditional fiberglass cast.  Diabetes Care. 2007;  30 586-590
• 289 Pieber T R, Holler A, Siebenhofer A et al. Evaluation of a structured teaching and treatment programme for type 2 diabetes in general practice in a rural area of Austria.  Diabet Med. 1995;  12 349-354
• 290 Pinzur M S, Stuck R M, Sage R et al. Syme ankle disarticulation in patients with diabetes.  J Bone Joint Surg [Am]. 2003;  85 1667-1672
• 291 Pinzur M S, Stuck R, Sage R et al. Benchmark analysis on diabetics at high risk for lower extremity amputation.  Foot Ankle Int. 1996;  17 695-700
• 292 Pitocco D, Ruotolo V, Caputo S et al. Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial.  Diabetes Care. 2005;  28 1214-1215
• 293 Pittet D, Wyssa B, Herter-Clavel C et al. Outcome of diabetic foot infections treated conservatively. A retrospective cohort study with long-term follow-up.  Arch Intern Med. 1999;  159 851-856
• 294 Plank J, Haas W, Rakovac I et al. Evaluation of the impact of chiropodist care in the secondary prevention of foot ulcerations in diabetic subjects.  Diabetes Care. 2003;  26 1691-1695
• 295 Pomposelli Jr F B, Arora S, Gibbons G W et al. Lower extremity arterial reconstruction in the very elderly: successful outcome preserves not only the limb but also residential status and ambulatory function.  Vasc Surg. 1998;  28 215-225
• 296 Pound N, Chipchase S, Treece K et al. Ulcer-free survival following management of foot ulcers in diabetes.  Diabetic Medicine. 2005;  22 1306-1309
• 297 Pua B B, Muhs B E, Maldonado T et al. Total-contact casting as an adjunct to promote healing of pressure ulcers in amputees.  Vascular & Endovascular Surgery. 2006;  40 135-140
• 298 Puttirutvong P. Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage.  J Med Assoc Thai. 2004;  87 66-72
• 299 Prompers L, Huijberts M, Apelqvist J et al. High prevalence of ischemia, infection and serious comorbidities in patients with diabetic foot disease in Europe; Baseline results from the Eurodiale study.  Diabetologia. 2007;  50
• 300 Prompers L, Schaper N, Apelqvist J et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study.  Diabetologia. 2008;  51 747-755
• 301 Quatresooz P, Kharfi M, Paquet P et al. Healing effect of ketanserin on chronic leg ulcers in patients with diabetes.  J Eur Acad Dermatol Venereol. 2006;  20 277-281
• 302 Ragnarsson-Tennvall G, Apelqvist J. Cost-effective management of diabetic foot ulcers.  PharmacoEconomics. 1997;  12 42-53
• 303 Ramsey S C, Newton K, Blough D. Incidence, Outcomes, and cost of foot ulcers in Patients with Diabetes.  Diabetes Care. 1999;  22 382-387
• 304 Rashid S T, Salman M, Agarwal S et al. Occult renal impairment is common in patients with peripheral vascular disease and normal serum creatinine.  Eur J Vasc Endovasc Surg. 2006;  32 294-299
• 305 Raviola C A, Nichter L S, Baker J D et al. Cost of treating advanced leg ischemia. Bypass graft vs primary amputation.  Arch Surg. 1988;  123 495-496
• 306 Rayman G, Malik R A, Sharma A K et al. Microvascular response to tissue injury and capillary ultrastructure in the foot of type 1 diabetic patients.  Clin Sc (Colch). 1995;  89 467-474
• 307 Redberg R F, Greenland P, Fuster V. Prevention Conference VI. Diabetes and cardiovascular disease. Writing Group III: Risk assessment for persons with diabetes.  Circulation. 2002;  105 e144-e152
• 308 Reiber G E, Boyko E J, Smith D G. Lower extremity foot ulcers and amputations in diabetes. Diabetes in America. 2nd ed. Washington: ED: DHHS; 1995
• 309 Reiber G E, Pecoraro R E, Koepsell T D. Risk factors for amputations in patients with diabetes mellitus. A case-control study.  Ann Int Med. 1992;  117 97-105
• 310 Reiber G E, Lipsky B A, Gibbons G W. The burden of diabetic foot ulcer.  Am J Surg. 1998;  176 (Suppl. II a) 5-10
• 311 Reiber G E, Vileikyte L, Boyko E J. Causal Pathways for Incident Lower-Extremity Ulcers in Patients With Diabetes From Two Settings.  Diabetes Care. 1999;  22 157-162
• 312 Reike H. Diabetische Osteoarthropathie und Charcot Fuß. In: Reike H, eds. Diabetisches Fußsyndrom. Berlin: De Gruyter; 1999: 69–80
• 313 Reike H. Inhaltliche und formale Strukturen für eine erfolgreiche Betreuung von Patienten mit diabetischem Fußsyndrom. In: Reike H Diabetisches Fußsyndrom. Berlin: De Gruyter; 1999: 191–204
• 314 Rith-Najarian S J, Stolusky T, Gohdes D M. Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria.  Diabetes Care. 1992;  15 1386-1389
• 315 Rivers S P, Scher L, Veith F J. Indications for distal arterial reconstruction in the presence of palpable pedal pulses.  J Vasc Surg. 1990;  12 552-557
• 316 Roberts D T, Taylor W D, Boyle J. Guidelines for treatment of onychomycosis.  British Journal of Dermatology. 2003;  148 402-410
• 317 Rogers L C, Bevilacqua N J, Armstrong D G. The use of marrow-derived stem cells to accelerate healing in chronic wounds.  Int Wound J. 2008;  5 20-25
• 318 Rolland Y, Duvauferrier R, Lucas A et al. Lower limb angiography: a prospective study comparing carbon dioxide with iodinated contrast material in 30 patients.  Am J Roentgenol. 1998;  171 333-337
• 319 Ronnemaa T, Hamalainen H, Toikka T et al. Evaluation of the impact of podiatrist care in the primary prevention of foot problems in diabetic subjects.  Diabetes Care. 1997;  20 1833-1837
• 320 Rümenapf G. Grenzzonenamputation bei Diabetikern – Offene Fragen und kritische Bewertung.  Zentralbl Chir. 2003;  128 726-733
• 321 Rümenapf G, Neufang A, Schmiedt W et al. Gefäßchirurgie bei Diabetikern mit Fußproblemen.  Dt Ärztebl. 2004;  101 3348-3354
• 322 Saap L J, Falanga V. Debridement performance index and its correlation with complete closure of diabetic foot ulcers.  Wound Repair Regen. 2002;  10 354-359
• 323 Sämann A, Tajiyeva O, Müller N et al. Prevalence of the diabetic foot syndrome at the primary care level in Germany: a cross-sectional study.  Diabet Med. 2008;  (5) 557-563
• 324 Sam A D2nd, Morasch M D, Collin J et al. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency.  J Vasc Surg. 2003;  38 313-318
• 325 Sanders L J, Frykberg R G. Diabetic neuropathic osteoarthropathy: the Charcot foot. In: Frykberg RD, ed. The high risk foot in diabetes mellitus. New York, NY: Churchill Livingstone; 1991: 297–338
• 326 Sanders L J. The Charcot foot: historical perspective 1827–2003.  Diabetes Metabolism Research and Reviews. 2004;  20 (Suppl 1) 9-12
• 327 Schömig M, Ritz E, Standl E et al. The Diabetic Foot in the Dialyzed Patient.  J Am Soc Nephrol. 2000;  11 1153-1159
• 328 Schofield C J, Libby G, Brennan G M et al. Mortality and Hospitalization in Patients after Amputation.  Diabetes Care. 2006;  29 2252-2256
• 329 Schon L C, Easley M E, Weinfeld S B. Charcot neuroarthropathy of the foot and ankle.  Clin Orthop. 1998;  349 116-131
• 330 Second European Consensus Document on Chronic Critical Ischaemia.  Eur J Vasc Surg. 1992;  6 (Suppl A) 1-32
• 331 Seebacher C, Ginter-Hanselmeyer G. Leitlinien der Dt. Dermatologischen Gesellschaft, der Deutschsprachigen Mykologischen Gesellschaft und des Berufsverbandes der Deutschen Dermatologen. Onychomykose. AWMF Leitlinienregister Nr. 013 / 003. 2002
• 332 Seebacher C, Korting H C. Leitlinien der Dt. Dermatologischen Gesellschaft, der Deutschsprachigen Mykologischen Gesellschaft. Tinea der freien Haut. AWMV Leitlinienregister Nr. 013 / 002. 2004
• 333 Seebacher C. Leitlinien der Dt. Dermatologischen Gesellschaft, der Deutschsprachigen Mykologischen Gesellschaft und des Berufsverbandes der Deutschen Dermatologen. Candidose der Haut. AWMF Leitlinienregister Nr. 013 / 005. 2005
• 334 Selby P L, Young M J, Boulton A JM. Bisphosphonates: A new treatment for diabetic Charcot neuroarthropathy?.  Diabet Med. 1994;  11 28-31
• 335 Senneville E, Yazdanpanah Y, Cazaubiel M. Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis.  J Antimicrob Chemotherap. 2001;  48 927-930
• 336 Senneville E, Lombart A, Beltrand E et al. Outcome of diabetic foot osteomyelitis treated nonsurgically: a retrospective cohort study.  Diabetes Care. 2008;  31 637-642
• 337 Senneville E, Melliez H, Beltrand E et al. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: Concordance with ulcer swap cultures.  Clinical Infectious Diseases. 2006;  42 57-62
• 338 Sheehan P, Jones P, Caselli A et al. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial.  Diabetes Care. 2003;  26 1879-1782
• 339 Sherman R A. Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy.  Diabetes Care. 2003;  26 446-451
• 340 Shone A, Burnside J, Chipchase S et al. Probing the validity of the probe-to-bone test in the diagnosis of osteomyelitis of the foot in diabetes (1).  Diabetes Care. 2006;  29 945
• 341 Siancore D R, Mueller M J, Diamond J E et al. Diabetic plantar ulcers treated by total contact casting.  Physical therapy. 1987;  67 1543-1549
• 342 Singh N, Armstrong D G, Lipsky B A. Preventing foot ulcers in patients with diabetes.  JAMA. 2005;  293 217-228
• 343 Smith F C, Shearman C P, Simms M H et al. Falsely elevated ankle pressures in severe leg ischaemia: the pole test – an alternative approach.  Eur J Vasc Surg. 1994;  8 408-412
• 344 Smith J. Debridement of diabetic foot ulcers. Cochrane Database Syst Rev 2002; (4): CD003556
• 345 Spraul M. Prävention des diabetischen Fußsyndroms.  Internist. 1999;  40 1056-1066
• 346 Spraul M, Schönbach A M, Mühlhauser I et al. Amputationen und Mortalität bei älteren, insulinpflichtigen Patienten mit Typ-2-Diabetes.  Zentralbl Chir. 1999;  124 25-31
• 347 Steed D L, Donohue D, Webster M et al. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers.  J Am Coll Surg. 1996;  183 61-64
• 348 Stiegler H, Standl E, Frank S et al. Failure of reducing lower extremity amputations in diabetic patients: results of two subsequent population based surveys in 1990 and 1995 in Germany.  Vasa. 1998;  27 10-14
• 349 Striesow F. Konfektionierte Spezialschuhe zur Ulkusrezidivprophylaxe beim diabetischen Fußsyndrom.  Med Klein. 1998;  93 695-700
• 350 Stockl K, Vanderplas A, Tafesse E et al. Costs of lower-extremity ulcers among patients with diabetes.  Diabetes Care. 2004;  27 2129-2134
• 351 Sumpio B E. Foot Ulcers.  New Engl J Med. 2000;  11 787-793
• 352 Taylor S M, Kalbaugh C A, Blackhurst D W et al. Preoperative clinical factors predict postoperative functional outcomes after major lower limb amputation: an analysis of 553 consecutive patients.  J Vasc Surg. 2005;  42 227-235
• 353 Tentolouris N, Jude E B, Smirnof I et al. Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic.  Diabet Med. 1999;  16 767-771
• 354 Tepel M, van der Giet M, Schwarzfeld C et al. Prevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by Acetylcysteine.  N Engl J Med. 2000;  343 180-184
• 355 The Vascular Surgical Society of Great Britain and Ireland. Critical limb Ischemia: Management and outcome. Report of a national survey.  Eur J Vasc Endovasc Surg. 1995;  10 108-113
• 356 Thomas S, Jones M, Shutler S et al. Using larvae in modern wound management.  J Wound Care. 1996;  5 60-69
• 357 The LEA Study Group . Comparing the incidence of lower extremity amputations across the world: the global lower limb extremity amputation study.  Diabetic Med. 1995;  12 14-18
• 358 Thivolet C, EI Farkh J, Petiot A. Measuring vibration sensations with graduated tuning fork: simple & reliable means to detect diabetic patients at risk of neuropathic foot ulceration.  Diabetes Care. 1990;  13 1077-1080
• 359 Thompson C, McWilliams T, Scott D et al. Importance of diabetic foot admissions at Middlemore Hospital.  N Z Med J. 1993;  12 178-180
• 360 Tooke J E, Brash P D. Microvascular Aspects of Diabetic Foot Disease.  Diabet Med. 1996;  13 26-29
• 361 Toprak O, Cirit M, Yesil M et al. Metabolic syndrome as a risk factor for contrast-induced nephropathy in non-diabetic elderly patients with renal impairment.  Kidney Blood Press Res. 2006;  29 2-9
• 362 Tovey F I. The manufacture of diabetic footwear.  Diabet Med. 1984;  1 69-71
• 363 Trautner C, Standl E, Haastert B et al. Geschätzte Anzahl von Amputationen in Deutschland.  Diabetes und Stoffwechsel. 1997;  6 199-202
• 364 Trautner C, Haastert B, Spraul M et al. Unchanged incidence of lower-limb amputations in a German city, 1990–1998.  Diabetes Care. 2001;  24 855-859
• 365 Trautner C, Haastert B, Mauckner P et al. Reduced incidence of lower-limb amputations in the diabetic population of a German city, 1990–2005: results of the Leverkusen Amputation Reduction Study (LARS).  Diabetes Care. 2007;  30 2633-2637
• 366 Trivedi H L, Moore H, Nasr S et al. A randomised prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity.  Nephron Clin Pract. 2003;  93 c29-c34
• 367 Tsang M W, Wong W K, Hung C S et al. Human epidermal growth factor enhances healing of diabetic foot ulcers.  Diabetes Care. 2003;  26 1856-1861
• 368 Uccioli L, Aldeghi A, Faglia E. Manufactured shoes in the prevention of diabetic foot ulcers.  Diabetes Care. 1995;  18 1376-1378
• 369 Valensi P, Girod I, Baron F et al. Quality of life and clinical correlates in patients with diabetic foot ulcers.  Diabetes & Metabolism. 2005;  31 263-271
• 370 Valk G D, Kriegsman D MW, Assendelft W JJ. Patient education for preventing diabetic foot ulceration. The Cochrane Database of Systematic Reviews 2001; 4: CD001488
• 371 Van der Feen C, Neijens F S, Kanters S DJM et al. Angiographic distribution of lower extremity atherosclerosis in patients with and without diabetes.  Diabet Med. 2002;  19 366-370
• 372 Van Gils C C, Wheeler L A, Mellstrom M et al. Amputation prevention by vascular surgery and podiatry collaboration in high-risk diabetic and nondiabetic patients. The Operation Desert Foot experience.  Diabetes Care. 1999;  22 678-683
• 373 Van Houtum W H, Lavery L H. Outcomes associated with diabetes-related amputations in the Netherlands and the State of California.  J Int Med. 1996;  240 227-231
• 374 Van Houtum W H, Lavery L A, Harkless L B. The costs of diabetes-related lower extremity amputations in the Netherlands.  Diabet Med. 1995;  12 777-781
• 375 Van Houtum W H, Lavery L H, Harkless L B. The impact of diabetes-related lower extremity amputations in the Netherlands.  J Diabetes Compl. 1996;  10 325-330
• 376 Van Houtum W H, Rauwerda J A, Ruwaard D et al. Reduction in diabetes-related lower-extremity amputations in the Netherlands: 1991–2000.  Diabetes Care. 2004;  27 1042-1046
• 377 Vazquez J R, Short B, Findlow A H et al. Outcomes of hyaluronan therapy in diabetic foot wounds.  Diabetes Res Clin Pract. 2003;  59 123-127
• 378 Venkatesan P, Lawn S, Macfarlane R M et al. Conservative management of osteomyelitis in the feet of diabetic patients.  Diabet Med. 1997;  14 487-490
• 379 Veves A, Falanga V, Armstrong D G et al. Apligraf Diabetic Foot Ulcer Study. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.  Diabetes Care. 2001;  24 290-295
• 380 Veves H, Masson E A, Fernando D FS, Boulton A JM. Use of experimental padded hosiery to reduce abnormal foot pressure in diabetic patients.  Diabetes Care. 1989;  12 653-655
• 381 Veves A, Sheehan P, Pham H T. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers.  Arch Surg. 2002;  137 822-827
• 382 Vileikyte L, Hutchings G, Hollis S. The tactile circumferential discriminator: A new, simple screening device to identify diabetic patients at risk of foot ulceration.  Diabetes Care. 1997;  20 623-626
• 383 Vileikyte L, Rubin R R, Leventhal H. Psychological aspects of diabetic neuropathic foot complications: an overview.  Diabetes Metabolism Research and Reviews. 2004;  20 (Suppl. 1) 13-18
• 384 Vileikyte L, Leventhal H, Gonzales J S et al. Diabetic peripheral neuropathy and depressive symptoms.  Diabetes Care. 2005;  10 2378-2383
• 385 Volaco A, Chantelau E, Richter B et al. Outcome of critical foot ischaemia in longstanding diabetic patients: a retrospective cohort study in a specialised tertiary care centre.  Vasa. 2004;  33 36-41
• 386 Wagner A H, Reike H, Angelkort B. Highly resistant pathogens in patients with diabetic foot syndrome with special reference to methicillin-resistant Staphylococcus aureus infections.  Dtsch Med Wochenschr. 2001;  126 1353-1356
• 387 Wagner F W. The Dysvascular foot: A system for diagnosis and treatment.  Foot and Ankle. 1981;  2 64-122
• 388 Walters D A, Gatling W, Mullee M A. The distribution and severity of diabetic foot disease: a community based study with comparison to a non-diabetic group.  Diabetic Med. 1992;  9 354-358
• 389 Waltin J N. Brain’s Diseases of the Nervous System. Oxford University Press, Oxford, New York, Toronto: 1977; 472, 857
• 390 Wheat L J, Allen S D, Henry M. Diabetic foot infections. Bacteriologic analysis.  Arch Intern Med. 1986;  146 1935-1940
• 391 Wieman T J, Smiell J M, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.  Diabetes Care. 1998;  21 822-827
• 392 Wild S H, Byrne C D, Smith F B et al. Low ankle-brachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the Edinburgh Artery Study.  Diabetes Care. 2006;  29 637-642
• 393 Williams D T, Harding K G, Price P. An evaluation of the efficacy of methods used in screening for lower-limb arterial disease in diabetes.  Diabetes Care. 2005;  28 2206-2210
• 394 Winter G D. Formation of the scab and the rate of epithelization of superficial wound in the in the skin of young domestic pig.  Nature. 1962;  193 293-294
• 395 Wölfle K D, Schaal J, Rittler S et al. Infrainguinal bypass grafting in patients with end-stage renal disease and critical limb ischaemia: Is it worthwhile?.  Zentralblatt für Chirurgie. 2003;  128 709-714
• 396 Woods S, Clever H U. Psychologische Aspekte des diabetischen Fußsyndroms.  Diabetologe. 2006;  2 18-26
• 397 Wrobel J S, Conolly J E. Making the diagnosis of osteomyelitis: the role of prevalence.  J Am Podiatr Med Assoc. 1998;  88 337-343
• 398 Wunderlich R P, Peters E J, Lavery L A. Systemic hyperbaric oxygen therapy: lower-extremity wound healing and the diabetic foot.  Diabetes Care. 2000;  23 1551-1555
• 399 Yamaguchi Y, Yoshida S, Sumikawa Y et al. Rapid healing of intractable diabetic foot ulcers with exposed bones following a novel therapy of exposing bone marrow cells and then grafting epidermal sheets.  Br J Dermatol. 2004;  151 1019-1028
• 400 Yeager R A, Moneta G L, Edwards J M et al. Predictors of outcome of forefoot surgery for ulceration and gangrene.  Am J Surg. 1998;  175 388-390
• 401 Young M, Boulton A JM. A Multicentre Study of the Prevalence of Diabetic Peripheral Neuropathy in the United Kingdom Hospital Clinic Population.  Diabetologia. 1993;  36 150-154
• 402 Young M J, Breddy J L, Veves A et al. The prediction of neuropathic foot ulceration using vibration perception thresholds.  Diabetes Care. 1994;  17 557-561
• 403 Young M J, Cavanagh P R, Thomas G et al. The effect of callus removal on dynamic foot pressures in diabetic patients.  Diabetic Med. 1992;  9 55-57
• 404 Zimny S, Schatz H, Pfohl M. Determinants and estimation of healing times in diabetic foot ulcers.  J Diabetes Compl. 2002;  16 327-332
• 405 Zimny S, Schatz H, Pfohl M. The role of limited joint mobility in diabetic patients with an at-risk foot.  Diabetes Care. 2004;  27 942-946